These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 36298443)
21. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555 [TBL] [Abstract][Full Text] [Related]
22. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen. Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458 [TBL] [Abstract][Full Text] [Related]
23. Outer Membrane Vesicles Coating Nano-Glycyrrhizic Acid Confers Protection Against Huang Y; Nan L; Xiao C; Dong J; Li K; Cheng J; Ji Q; Wei Q; Bao G; Liu Y Int J Nanomedicine; 2022; 17():647-663. PubMed ID: 35177904 [TBL] [Abstract][Full Text] [Related]
24. Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model. Lee TY; Kim CU; Bae EH; Seo SH; Jeong DG; Yoon SW; Chang KT; Kim YS; Kim SH; Kim DJ Vaccine; 2017 Jan; 35(4):586-595. PubMed ID: 28024958 [TBL] [Abstract][Full Text] [Related]
25. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215 [TBL] [Abstract][Full Text] [Related]
26. Outer Membrane Vesicle Induction and Isolation for Vaccine Development. Balhuizen MD; Veldhuizen EJA; Haagsman HP Front Microbiol; 2021; 12():629090. PubMed ID: 33613498 [TBL] [Abstract][Full Text] [Related]
27. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. Zhu Z; Antenucci F; Villumsen KR; Bojesen AM mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691 [TBL] [Abstract][Full Text] [Related]
34. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation. van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988 [TBL] [Abstract][Full Text] [Related]
35. PmrC (EptA) and CptA Negatively Affect Outer Membrane Vesicle Production in Citrobacter rodentium. Sinha A; Nyongesa S; Viau C; Gruenheid S; Veyrier FJ; Le Moual H J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30670547 [TBL] [Abstract][Full Text] [Related]
36. Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The König E; Gagliardi A; Riedmiller I; Andretta C; Tomasi M; Irene C; Frattini L; Zanella I; Berti F; Grandi A; Caproni E; Fantappiè L; Grandi G Front Immunol; 2021; 12():752168. PubMed ID: 34819933 [TBL] [Abstract][Full Text] [Related]
37. Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory. Izeli Portilho A; Araujo Correa V; Dos Santos Cirqueira C; De Gaspari E Immunol Invest; 2022 Oct; 51(7):2066-2085. PubMed ID: 35950702 [TBL] [Abstract][Full Text] [Related]
38. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles. Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064 [TBL] [Abstract][Full Text] [Related]
39. Construction and assessment of the immunogenicity and bactericidal activity of fusion protein porin A from Afrough P; Asadi Karam MR; Vaziri F; Behrouzi A; Siadat SD Iran J Basic Med Sci; 2020 Jun; 23(6):737-743. PubMed ID: 32695289 [TBL] [Abstract][Full Text] [Related]
40. Rapid prototyping vaccine approach in mice against multi-drug resistant Gram-negative organisms from clinical isolates based on outer membrane vesicles. Pritsch M; Ben Khaled N; Liegl G; Schubert S; Hoelscher M; Woischke C; Arens N; Thorn-Seshold J; Kammermeier S; Wieser A Microbiol Immunol; 2021 May; 65(5):214-227. PubMed ID: 33650163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]